Search Results - "Ramroth, J."

Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma by Jones, D.A., Candio, P., Shakir, R., Ramroth, J., Wolstenholme, J., Gray, A.M., Cutter, D.J., Ntentas, G.

“…Radiotherapy for Hodgkin lymphoma leads to the irradiation of organs at risk (OAR), which may confer excess risks of late effects. Comparative dosimetry…”
Get full text

OC-0292 Estimating risk of radiation toxicity for lymphoma patients using pre-chemotherapy PET-CT scans by Shakir, R., Butterworth, V., Ramroth, J., Cutter, D., Ntentas, G.

Get full text

An Excess Mortality Risk Analysis of Proton Beam versus Optimal Photon Radiotherapy for Mediastinal Hodgkin Lymphoma: Who May Benefit Most? by Ntentas, G., Dedeckova, K., Andrilik, M., Shakir, R., Aznar, M.C., Ramroth, J., Begum, R., Darby, S., Mikhaeel, G., Cutter, D.

Get full text

OC-0295 Colorectal cancer risk following radiotherapy and procarbazine for Hodgkin lymphoma by Shakir, R., Geurts, Y., Ntentas, G., Aleman, B., Ramroth, J., John, K., Janus, C., Krol, A., Roesink, J., van den Maazen, R., Zijlstra, J., van Leeuwen, F., Cutter, D., Schaapveld, M.

Get full text